Open AccessRandomized Trial to Compare Smoking Cessation Rates of Snus, With and Without Smokeless Tobacco Health-Related Information, and a Nicotine Lozenge
Author(s) -
Paul R. Nelson,
Peter Chen,
Deena R. Battista,
Janine L. Pillitteri,
Saul Shiffman
Publication year - 2018
Publication title -
nicotine and tobacco research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.338
H-Index - 113
eISSN - 1469-994X
pISSN - 1462-2203
DOI - 10.1093/ntr/nty011
Subject(s) - snus , medicine , smokeless tobacco , smoking cessation , lozenge , abstinence , nicotine , nicotine replacement therapy , randomized controlled trial , nicotine patch , quitline , relative risk , environmental health , psychiatry , population , confidence interval , placebo , tobacco use , archaeology , history , pathology , alternative medicine
Nicotine replacement medications are moderately effective in increasing quit rates. However, some smokers reject such aids, suggesting the value of considering alternative options. Snus, a smokeless tobacco product with low nitrosamine content, could offer an alternative. This study compared smoking cessation rates for snus, with and without information about reduced risk relative to smoking, with a nicotine lozenge (without relative risk information).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom